Mortgage Marketshare Module
- Accurately track commercial and residential lending, measure sales performance against competition and market activity, identify high-performing competitors, and locate and target emerging markets.
  
  LEARN MORE >>
Loan Originator Module
- Access the largest and most comprehensive mortgage loan origination database in New England with round-the-clock interactive access and weekly trend updates.
  
  LEARN MORE >>
Marketing Lists
- Gain access to the most accurate and detailed transaction information in the country and offers a range of marketing lists for more than 130 million households (covering 94% of the U.S. population).
  
  LEARN MORE >>
Custom Research
- Powered by one-of-a-kind real estate, mortgage, and loan origination data, The Warren Group provides custom solutions for your research projects, database expansion, and strategic planning.
  
  LEARN MORE >>
Real Estate Records Search
- Access the largest and most complete real estate database in New England, including sales, price trends, liens and foreclosures.
  
  LEARN MORE >>

Pharma Company Renews In Seaport

Sep 14, 2016 | Reprints | Unlock Link | Print

Acetylon Pharmaceuticals has renewed its 13,600-square-foot lease at 451 D St. in Boston’s Seaport District.

McPherson Corp.’s Keith Coulter represented Acetylon in the transaction. CBRE/NE’s Bill Crean and Jonathan Freni represented owner Meritage Properties. The building is owned in a joint venture between Meritage Properties, State Street Global Advisors and Commonwealth Ventures.

Acetylon is developing treatments for multiple myeloma and lymphoma. It moved to the Seaport location, then known as Seaport Center, from the South End in 2011.

451 D Street offers shuttle service to North and South Stations and is undergoing lobby renovations and the installation of a 3,000-square-foot amenity center including a lounge, kitchen, games and conference center.

B&T Daily